ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,135Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 1383

$962K Total Retail Price of All Prescriptions

Rank: 66 out of 1383

605 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 605 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 605 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 13,142 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
WARFARIN SODIUM 594 552 1 13
LISINOPRIL 550 444 2 3
LEVOTHYROXINE SODIUM 460 392 3 4
FUROSEMIDE 431 403 4 7
SIMVASTATIN 390 324 5 2
HYDROCODONE-ACETAMINOPHEN 382 190 S3 6 1
OMEPRAZOLE 281 259 7 5
MELOXICAM 273 233 8 20
GABAPENTIN 264 212 9 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 263 228 10 27
METFORMIN HCL 259 200 11 8
AMLODIPINE BESYLATE 252 234 12 6
HYDROCHLOROTHIAZIDE 249 225 13 10
METOPROLOL TARTRATE 235 216 14 9
CIPROFLOXACIN HCL 214 183 15 54
NAMENDA 207 207 16 49
SERTRALINE HCL 205 188 17 21
FLUOXETINE HCL 196 180 18 52
DONEPEZIL HCL 193 193 19 35
CITALOPRAM HBR 179 147 20 15
ZOLPIDEM TARTRATE 171 122 21 17
LOVASTATIN 170 123 22 22
VERAPAMIL ER 169 148 23 84
DIVALPROEX SODIUM 160 150 24 78
EXELON 154 154 25 117
RANITIDINE HCL 142 130 26 19
METOPROLOL SUCCINATE 142 101 26 29
POTASSIUM CHLORIDE 140 134 28 12
CYMBALTA 132 88 29 53
DIGOXIN 132 130 29 59
KLOR-CON M20 129 117 31 100
PANTOPRAZOLE SODIUM 124 80 32 32
RISPERIDONE 123 123 33 71
ATENOLOL 119 110 34 16
ESCITALOPRAM OXALATE 115 106 35 99
CLONIDINE HCL 106 75 36 44
ALENDRONATE SODIUM 103 84 37 37
TAMSULOSIN HCL 102 92 38 30
DIOVAN HCT 98 74 39 103
LACTULOSE 96 40 40 128
NEXIUM 96 54 40 26
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 79 42 89
LEVETIRACETAM 94 68 43 134
ROPINIROLE HCL 93 71 44 79
LEVEMIR 92 85 45 145
AMOXICILLIN 90 63 46 119
ATORVASTATIN CALCIUM 86 81 47 18
CLOPIDOGREL 85 73 48 28
FLUTICASONE PROPIONATE 81 56 49 39
GLIPIZIDE ER 79 79 50 157
PROMETHAZINE HCL 77 56 R 51 56
GEMFIBROZIL 77 74 51 90
IPRATROPIUM-ALBUTEROL 76 74 53 138
GLIPIZIDE 75 61 54 98
LANTUS 74 64 55 50
CARISOPRODOL 74 11 R 55 76
AMITRIPTYLINE HCL 72 31 R 57 57
SUCRALFATE 72 63 57 190
EVISTA 72 72 57 152
CARBIDOPA-LEVODOPA 71 70 60 108
CARVEDILOL 70 65 61 24
PRAVASTATIN SODIUM 69 48 62 14
SPIRONOLACTONE 68 60 63 67
NOVOLIN R 67 62 64 167
ABILIFY 66 37 65 178
ADVAIR DISKUS 65 57 66 63
MIRTAZAPINE 65 57 66 51
ALLOPURINOL 64 54 68 33
PLAVIX 64 48 68 43
PHENYTOIN SODIUM EXTENDED 63 20 70 137
CYCLOBENZAPRINE HCL 63 19 R 70 69
QUETIAPINE FUMARATE 63 52 70 70
ETODOLAC 63 59 70 198
CEPHALEXIN 60 48 74 87
DIOVAN 57 57 75 58
METOCLOPRAMIDE HCL 56 45 76 127
CEFTRIAXONE 54 50 77 175
NITROFURANTOIN MONO-MACRO 54 50 77 193
LOSARTAN POTASSIUM 54 53 77 23
TIZANIDINE HCL 53 32 80 104
TRAZODONE HCL 53 33 80 36
HYDROCODONE BIT-IBUPROFEN 51 36 S3 82 333
MEGESTROL ACETATE 50 46 R 83 170
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.